TY - ELEC TI - Vigilancia COVID trabajadores Salud Dic 6 4 pm 2022.docx UR - https://uredu-my.sharepoint.com/:w:/r/personal/carlos_trillos_urosario_edu_co/_layouts/15/Doc.aspx?sourcedoc=%7BEC4F8E2F-6F14-45AF-AF80-699BBF8E3B69%7D&file=Vigilancia%20COVID%20trabajadores%20Salud%20Dic%206%204%20pm%202022.docx&action=default&mobileredirect=true Y2 - 2022/12/07/00:43:43 L2 - https://uredu-my.sharepoint.com/:w:/r/personal/carlos_trillos_urosario_edu_co/_layouts/15/Doc.aspx?sourcedoc=%7BEC4F8E2F-6F14-45AF-AF80-699BBF8E3B69%7D&file=Vigilancia%20COVID%20trabajadores%20Salud%20Dic%206%204%20pm%202022.docx&action=default&mobileredirect=true ER - TY - GEN TI - Decreto 1374 de 2020. Por el cual se optimiza el Programa de Pruebas, Rastreo y Aislamiento Selectivo Sostenible - PRASS, para el monitoreo y seguimiento de casos y contactos de COVID – 19 en Colombia AU - Gobierno de Colombia DA - 2020/// PY - 2020 LA - Español UR - https://www.funcionpublica.gov.co/eva/gestornormativo/norma.php?i=143538#:~:text=15.1.,COV%2D2%2F%20COVID%2019.&text=ART%C3%8DCULO%2016. ER - TY - ELEC TI - Guía clínica para la atención al paciente long covid/covid persistente AU - Sociedad española de médicos generales y familia DA - 2021/// PY - 2021 LA - Español UR - https://www.semg.es/images/2021/Documentos/GUIA_CLINICA_COVID_Persistent_20210501_breviario.pdf ER - TY - ELEC TI - Resolución 777 de 2021 Ministerio de Salud y Protección Social AU - Gobierno de Colombia DA - 2021/// PY - 2021 LA - Español UR - https://www.funcionpublica.gov.co/eva/gestornormativo/norma.php?i=163987#:~:text=ART%C3%8DCULO%206.,integral%20de%20la%20presente%20resoluci%C3%B3n. ER - TY - ELEC TI - The Covid-19 HEalth caRe wOrkErS (HEROES) Study (HEROES) AU - Columbia University DA - 2021/04/01/ PY - 2021 LA - inglés UR - https://clinicaltrials.gov/show/NCT04352634 ER - TY - ELEC TI - COVID-19 en Colombia AU - Instituto Nacional de Salud DA - 2022/// PY - 2022 LA - Español UR - https://www.ins.gov.co/Noticias/Paginas/Coronavirus.aspx Y2 - 2022/11/08/ ER - TY - ELEC TI - Colombia COVID - Coronavirus Statistics - Worldometer AU - Worldometer DA - 2022/// PY - 2022 UR - https://www.worldometers.info/coronavirus/country/colombia/ Y2 - 2022/09/13/ L2 - https://www.worldometers.info/coronavirus/country/colombia/ ER - TY - BOOK TI - Dos años de pandemia de COVID-19 en América Latina y el Caribe: reflexiones para avanzar hacia sistemas de salud y de protección social universales, integrales, sostenibles y resilientes AU - Cid, Camilo AU - Marinho, María CY - Santiago de Chile DA - 2022/// PY - 2022 DP - Zotero LA - es PB - Naciones Unidas - CEPAL UR - https://repositorio.cepal.org/bitstream/handle/11362/47914/1/S2200413_es.pdf L1 - https://repositorio.cepal.org/bitstream/handle/11362/47914/1/S2200413_es.pdf ER - TY - ELEC TI - Vigilancia COVID trabajadores Salud Dic 6 3 pm 2022.docx UR - https://uredu-my.sharepoint.com/:w:/r/personal/carlos_trillos_urosario_edu_co/_layouts/15/Doc.aspx?sourcedoc=%7BB4B296DB-63F2-428D-8150-4550AEAB6990%7D&file=Vigilancia%20COVID%20trabajadores%20Salud%20Dic%206%203%20pm%202022.docx&action=default&mobileredirect=true Y2 - 2022/12/06/20:58:15 L2 - https://uredu-my.sharepoint.com/:w:/r/personal/carlos_trillos_urosario_edu_co/_layouts/15/Doc.aspx?sourcedoc=%7BB4B296DB-63F2-428D-8150-4550AEAB6990%7D&file=Vigilancia%20COVID%20trabajadores%20Salud%20Dic%206%203%20pm%202022.docx&action=default&mobileredirect=true ER - TY - ELEC TI - Vacunación contra COVID-19 AU - Ministerio de Salud DA - 2022/// PY - 2022 LA - Español UR - https://www.minsalud.gov.co/salud/publica/Vacunacion/Paginas/Vacunacion-covid-19.aspx ER - TY - ELEC TI - Tracking SARS-CoV-2 variants AU - World Health Organization DA - 2022/12/01/ PY - 2022 LA - Inglés UR - https://www.who.int/activities/tracking-SARS-CoV-2-variants ER - TY - JOUR TI - The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19 AU - Klok, Frederikus A. AU - Boon, Gudula J.A.M. AU - Barco, Stefano AU - Endres, Matthias AU - Geelhoed, J.J. Miranda AU - Knauss, Samuel AU - Rezek, Spencer A. AU - Spruit, Martijn A. AU - Vehreschild, Jörg AU - Siegerink, Bob T2 - European Respiratory Journal DA - 2020/07// PY - 2020 DO - 10.1183/13993003.01494-2020 DP - DOI.org (Crossref) VL - 56 IS - 1 SP - 2001494 J2 - Eur Respir J LA - en SN - 0903-1936, 1399-3003 ST - The Post-COVID-19 Functional Status scale UR - http://erj.ersjournals.com/lookup/doi/10.1183/13993003.01494-2020 Y2 - 2022/11/21/16:21:54 L1 - https://erj.ersjournals.com/content/erj/56/1/2001494.full.pdf ER - TY - ELEC TI - Reinfections and COVID-19 AU - National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases T2 - CDC Centers for disease control and prevention DA - 2022/09/09/ PY - 2022 LA - Ingles ST - COVID-19 UR - https://www.cdc.gov/coronavirus/2019-ncov/your-health/reinfection.html#:~:text=Reinfection%20with%20the%20virus%20that,some%20protection%20from%20repeat%20infections.%20%20%20%E2%80%94-Yahav%20D,%20Yelin%20D,%20Eckerle%20I,%20Eberhardt%20CS,%20Wang%20J,%20Cao%20B,%20Kaiser%20L.%20Definitions%20for%20coronavirus%20disease%202019%20reinfection,%20relapse%20and%20PCR%20re-positivity.%20Clin%20Microbiol%20Infect.%202021%20Mar;27(3):315-318.%20doi:%2010.1016/j.cmi.2020.11.028.%20Epub%202020%20Dec%205.%20PMID:%2033285276;%20PMCID:%20PMC7718119.%20%20%20%E2%80%94---%20Lara%20J%20Akinbami,%20Brad%20J%20Biggerstaff,%20Philip%20A%20Chan,%20Emily%20McGibbon,%20Preeti%20Pathela,%20Lyle%20R%20Petersen,%20Reinfection%20With%20Severe%20Acute%20Respiratory%20Syndrome%20Coronavirus%202%20Among%20Previously%20Infected%20Healthcare%20Personnel%20and%20First%20Responders,%20Clinical%20Infectious%20Diseases,%202021;,%20ciab952,%20https://doi.org/10.1093/cid/ciab952%20) ER - TY - JOUR TI - Reinfección por virus del sarscov-2 en un trabajador de la salud AU - Giraldo Ospina, Carlos AU - Giraldo Lopez, Karol T2 - Arch Med (Manizales) AB - Se presenta un caso de probable reinfección por COVID-19 en población trabajadora de la salud. Paciente femenina de 50 años (de Pereira, Colombia) con antecedentes de dislipidemia, apendicectomía e histerectomía, alérgica a la penicilina. Detectada como positiva para infección por COVID-19 el 25/04/2020 con negativización de la PCR el 6/05/2020 y posterior curso asintomática durante 233 días, captada por síntomas generales dados por: astenia, mialgias y cefalea el día 23/12/2020; nuevo reporte positivo del 26/12/2020 con persistencia de disnea sin otros hallazgos rele-vantes al examen físico, cursando con adecuada evolución a la fecha. Se considera como probable reinfección por COVID-19 de acuerdo a los lineamientos propuestos por la OMS, caso confirmado por criterio epidemiológico de prueba RT-PCR negativa durante el primer episodio de infección; puede tratarse de la acción de una nueva cepa para COVID-19. DA - 2021/03/26/ PY - 2021 SP - 627 EP - 633 LA - Español UR - https://doi.org/10.30554/archmed.21.2.4162.2021 ER - TY - JOUR TI - Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021 AU - Cavanaugh, Alyson M. AU - Spicer, Kevin B. AU - Thoroughman, Douglas AU - Glick, Connor AU - Winter, Kathleen T2 - MMWR. Morbidity and Mortality Weekly Report DA - 2021/08/13/ PY - 2021 DO - 10.15585/mmwr.mm7032e1 DP - DOI.org (Crossref) VL - 70 IS - 32 SP - 1081 EP - 1083 J2 - MMWR Morb. Mortal. Wkly. Rep. SN - 0149-2195, 1545-861X UR - http://www.cdc.gov/mmwr/volumes/70/wr/mm7032e1.htm?s_cid=mm7032e1_w Y2 - 2022/11/21/16:21:06 L1 - https://www.cdc.gov/mmwr/volumes/70/wr/pdfs/mm7032e1-H.pdf ER - TY - JOUR TI - Pulmonary function and chest computed tomography abnormalities 6–12 months after recovery from COVID-19: a systematic review and meta-analysis AU - Lee, Jong Hyuk AU - Yim, Jae-Joon AU - Park, Jimyung T2 - Respiratory Research AB - Abstract Background Some coronavirus disease 2019 (COVID-19) survivors experience prolonged and varying symptoms, a condition termed post-acute COVID-19 syndrome (PACS). However, the prevalence of chronic pulmonary sequelae of PACS during long-term follow-up remains unclear. Several studies have examined this issue and reported heterogeneous results. Methods We conducted a systematic review and meta-analysis using a random-effects model to estimate the pooled prevalence of the pulmonary sequelae of COVID-19, as demonstrated by pulmonary function testing (PFT) and chest computed tomography (CT) performed at least 6 months after initial infection. PubMed, Embase, and Cochrane Library databases were searched from January 1, 2020 to December 31, 2021 to identify related studies. We investigated whether the prevalence of pulmonary sequelae decreased over time and attempted to identify the factors associated with their development by performing multiple subgroup and meta-regression analyses. Results Of the 18,062 studies identified, 30 met our eligibility criteria. Among these studies, 25 and 22 had follow-up PFT and chest CT data, respectively. The follow-up durations were approximately 6 and 12 months in 18 and 12 studies, respectively. Impaired diffusion capacity was the most common abnormality on PFT (pooled prevalence 35%, 95% confidence interval [CI] 30–41%) with a prevalence of 39% (95% CI 34–45%) and 31% (95% CI 21–40%) in the 6-month and 12-month follow-up studies, respectively ( P  = 0.115). Restrictive pulmonary dysfunction evident as reduced forced vital capacity was less frequent (pooled prevalence 8%, 95% CI 6–11%); however, its prevalence was lower in the 12-month follow-up studies than in the 6-month follow-up studies (5% [95% CI 3–7%] vs. 13% [95% CI 8–19%], P  = 0.006). On follow-up chest CT, the pooled prevalence of persistent ground-glass opacities and pulmonary fibrosis was 34% (95% CI 24–44%) and 32% (95% CI 23–40%), respectively, and the prevalence did not decrease over time. As every meta-analysis showed significant between-study heterogeneity, subgroup and meta-regression analyses were performed to identify potential effect modifiers; the severity of index infection was associated with the prevalence of impaired diffusion capacity and pulmonary fibrosis. Conclusions A substantial number of COVID-19 survivors displayed pulmonary sequelae as part of PACS. Except for restrictive pulmonary dysfunction, the prevalence of these sequelae did not decrease until 1 year after initial infection. Considering the association between the severity of acute COVID-19 and risk of pulmonary sequelae, patients who recover from severe COVID-19 require close respiratory follow-up. Systematic review registration number PROSPERO CRD42021234357 DA - 2022/09/06/ PY - 2022 DO - 10.1186/s12931-022-02163-x DP - DOI.org (Crossref) VL - 23 IS - 1 SP - 233 J2 - Respir Res LA - en SN - 1465-993X ST - Pulmonary function and chest computed tomography abnormalities 6–12 months after recovery from COVID-19 UR - https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-022-02163-x Y2 - 2022/11/21/16:19:12 L1 - https://respiratory-research.biomedcentral.com/counter/pdf/10.1186/s12931-022-02163-x ER - TY - RPRT TI - The Covid-19 HEalth caRe wOrkErS (HEROES) Study (HEROES) AU - Columbia University AU - Rubén Alvarado, PhD DA - 2021/// PY - 2021 UR - https://clinicaltrials.gov/show/NCT04352634 AN - edsclt.NCT04352634 DB - ClinicalTrials.gov Y2 - 2022/11/21/ ER - TY - ELEC TI - Situación de la Región de las Américas por el brote de COVID-19 Al 05 de diciembre de 2022, 07:30 (EST) AU - Organización Panamericana de Salud T2 - Brote de enfermedad por el Coronavirus (COVID-19) DA - 2022/// PY - 2022 LA - Español UR - https://www.paho.org/es/temas/coronavirus/brote-enfermedad-por-coronavirus-covid-19?gclid=Cj0KCQiA7bucBhCeARIsAIOwr-_Yha59UbFzS8Ta9lnTUyob2B4y1Bd4HAlwOMSdp1h6nTqhvIz753AaAtEdEALw_wcB ER - TY - JOUR TI - Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 Among Previously Infected Healthcare Personnel and First Responders AU - Akinbami, Lara J AU - Biggerstaff, Brad J AU - Chan, Philip A AU - McGibbon, Emily AU - Pathela, Preeti AU - Petersen, Lyle R T2 - Clinical Infectious Diseases AB - Abstract Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus testing among first responders and healthcare personnel who participated in a May 2020–August 2020 serosurvey that assessed spike protein antibodies provided an opportunity to assess reinfection. Methods Serology survey data were merged with virus testing results from Rhode Island (1 March 2020–17 February 2021) and New York City (10 March 2020–14 December 2020). Participants with a positive virus test ≥14 days before their serology test were included. Reinfection was defined as a second positive SARS-CoV-2 test ≥90 days after the first positive test. The association between serostatus and reinfection was assessed with a proportional hazards model. Results Among 1572 previously infected persons, 40 (2.5%) were reinfected. Reinfection differed by serostatus: 8.4% among seronegative vs 1.9% among seropositive participants (P < .0001). Most reinfections occurred among Rhode Island nursing home and corrections personnel (n = 30) who were most frequently tested (mean 30.3 tests vs 4.6 for other Rhode Island and 2.3 for New York City participants). The adjusted hazard ratio (aHR) for reinfection in seropositive vs seronegative persons was 0.41 (95% confidence interval [CI], .20–.81). Exposure to a household member with coronavirus disease 2019 (COVID-19) before the serosurvey was also protective (aHR, 0.34; 95% CI, .13–.89). Conclusions Reinfections were uncommon among previously infected persons over a 9-month period that preceded widespread variant circulation. Seropositivity decreased reinfection risk. Lower reinfection risk associated with exposure to a household member with COVID-19 may reflect subsequently reduced household transmission. DA - 2022/08/24/ PY - 2022 DO - 10.1093/cid/ciab952 DP - DOI.org (Crossref) VL - 75 IS - 1 SP - e201 EP - e207 LA - en SN - 1058-4838, 1537-6591 UR - https://academic.oup.com/cid/article/75/1/e201/6428613 Y2 - 2022/11/21/16:20:50 L1 - https://academic.oup.com/cid/article-pdf/75/1/e201/45514369/ciab952.pdf ER - TY - JOUR TI - Public Health Surveillance Systems: Recent Advances in Their Use and Evaluation AU - Groseclose, Samuel L. AU - Buckeridge, David L. T2 - Annual Review of Public Health AB - Surveillance is critical for improving population health. Public health surveillance systems generate information that drives action, and the data must be of sufficient quality and with a resolution and timeliness that matches objectives. In the context of scientific advances in public health surveillance, changing health care and public health environments, and rapidly evolving technologies, the aim of this article is to review public health surveillance systems. We consider their current use to increase the efficiency and effectiveness of the public health system, the role of system stakeholders, the analysis and interpretation of surveillance data, approaches to system monitoring and evaluation, and opportunities for future advances in terms of increased scientific rigor, outcomes-focused research, and health informatics. DA - 2017/03/20/ PY - 2017 DO - 10.1146/annurev-publhealth-031816-044348 DP - DOI.org (Crossref) VL - 38 IS - 1 SP - 57 EP - 79 J2 - Annu. Rev. Public Health LA - en SN - 0163-7525, 1545-2093 ST - Public Health Surveillance Systems UR - https://www.annualreviews.org/doi/10.1146/annurev-publhealth-031816-044348 Y2 - 2022/12/06/18:34:43 L1 - http://www.annualreviews.org/doi/pdf/10.1146/annurev-publhealth-031816-044348 ER - TY - ELEC TI - Public health surveillance for COVID-19: interim guidance AU - World Health Organization DA - 2022//07/ PY - 2022 UR - https://www.who.int/publications/i/item/WHO-2019-nCoV-SurveillanceGuidance-2022.2 ER - TY - JOUR TI - Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis AU - Maglietta, Giuseppe AU - Diodati, Francesca AU - Puntoni, Matteo AU - Lazzarelli, Silvia AU - Marcomini, Barbara AU - Patrizi, Laura AU - Caminiti, Caterina T2 - Journal of Clinical Medicine AB - Evidence shows that a substantial proportion of patients with COVID-19 experiences long-term consequences of the disease, but the predisposing factors are poorly understood. We conducted a systematic review and meta-analysis to identify factors present during COVID-19 hospitalization associated with an increased risk of exhibiting new or persisting symptoms (Post-COVID-19 Syndrome, PCS). MedLine and WebOfScience were last searched on 30 September 2021. We included English language clinical trials and observational studies investigating prognostic factors for PCS in adults previously hospitalized for COVID-19, reporting at least one individual prospective follow-up of minimum 12 weeks. Two authors independently assessed risk of bias, which was judged generally moderate. Risk factors were included in the analysis if their association with PCS was investigated by at least two studies. To summarize the prognostic effect of each factor (or group of factors), odds ratios were estimated using raw data. Overall, 20 articles met the inclusion criteria, involving 13,340 patients. Associations were statistically significant for two factors: female sex with any symptoms (OR 1.52; 95% CI 1.27–1.82), with mental health symptoms (OR 1.67, 95% CI 1.21–2.29) and with fatigue (OR 1.54, 95% CI 1.32–1.79); acute disease severity with respiratory symptoms (OR 1.66, 95% CI 1.03–2.68). The I² statistics tests were calculated to quantify the degree of study heterogeneity. This is the first meta-analysis measuring the association between factors present during COVID-19 hospitalization and long-term sequelae. The role of female sex and acute disease severity as independent prognostic factors must be confirmed in robust longitudinal studies with longer follow-up. Identifying populations at greatest risk for PCS can enable the development of targeted prevention and management strategies. Systematic review registration: PROSPERO CRD42021253467. DA - 2022/03/11/ PY - 2022 DO - 10.3390/jcm11061541 DP - DOI.org (Crossref) VL - 11 IS - 6 SP - 1541 J2 - JCM LA - en SN - 2077-0383 ST - Prognostic Factors for Post-COVID-19 Syndrome UR - https://www.mdpi.com/2077-0383/11/6/1541 Y2 - 2022/11/21/16:19:35 L1 - https://www.mdpi.com/2077-0383/11/6/1541/pdf?version=1646985956 ER - TY - JOUR TI - Psychiatric and neuropsychiatric sequelae of COVID-19 – A systematic review AU - Schou, Thor Mertz AU - Joca, Samia AU - Wegener, Gregers AU - Bay-Richter, Cecilie T2 - Brain, Behavior, and Immunity DA - 2021/10// PY - 2021 DO - 10.1016/j.bbi.2021.07.018 DP - DOI.org (Crossref) VL - 97 SP - 328 EP - 348 J2 - Brain, Behavior, and Immunity LA - en SN - 08891591 UR - https://linkinghub.elsevier.com/retrieve/pii/S0889159121002816 Y2 - 2022/11/21/16:18:22 L1 - https://www.sciencedirect.com/science/article/pii/S0889159121002816/pdfft?md5=08746af3ee7fb07ab75920830645a6f7&pid=1-s2.0-S0889159121002816-main.pdf&isDTMRedir=Y ER - TY - GEN TI - Procedimiento de actuación para los servicios de prevención de riesgos laborales frente a la exposición al SARS-COV-2 AU - Ministerio de Sanidad de España, de España DA - 2022/06/06/ PY - 2022 UR - https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/Proteccion_Trabajadores_SARS-CoV-2.pdf ER - TY - JOUR TI - Post-COVID-19 fatigue: A systematic review AU - Joli, Jian AU - Buck, Patrizia AU - Zipfel, Stephan AU - Stengel, Andreas T2 - Frontiers in Psychiatry AB - Fatigue is recognized as one of the most commonly presented long-term complaints in individuals previously infected with SARS-CoV-2. This systematic review was performed to describe symptoms, etiology, possible risk factors related to post-COVID-19 fatigue and the therapeutic approaches used for the treatment of post-COVID-19 fatigue. For the systematic literature search the databases PubMed, Web of Science, Cochrane Library, and PsycInfo were used. All articles that met the inclusion criteria were analyzed for demographics, clinical data and treatment. Included were studies which focused on an adult population (18–65 years old); elderly patients and patients with chronic somatic diseases which can also cause fatigue were excluded. We identified 2,851, screened 2,193 and finally included 20 studies with moderate to high methodological quality, encompassing 5,629 participants. Potential risk factors for post-COVID-19 fatigue were old age, female sex, severe clinical status in the acute phase of infection, a high number of comorbidities, and a prediagnosis of depression/anxiety. Lastly, a possible autoimmune etiology was suspected. Several treatment approaches have been tested mostly in small and uncontrolled studies so far: a Chinese herbal formulation improved breathlessness and fatigue. Moreover, molecular hydrogen (H 2 ) inhalation had beneficial health effects in terms of improved physical (6-min walking test) and respiratory function in patients with post-COVID-19. Patients also noticed improvement in fatigue after undergoing hyperbaric oxygen therapy (HBOT) and enhanced external counterpulsation (EECP). Lastly. muscle strength and physical function were improved after undergoing an 8-weeks biweekly physical therapy course including aerobic training, strengthening exercises, diaphragmatic breathing techniques, and mindfulness training. However, larger and controlled studies e.g., investigating the effect of physical and / or psychotherapy for patients with post-COVID-19 fatigue are urgently warranted. Systematic Review Registration Unique Identifier: CRD42022320676, https://www.crd.york.ac.uk/PROSPERO/ . DA - 2022/08/11/ PY - 2022 DO - 10.3389/fpsyt.2022.947973 DP - DOI.org (Crossref) VL - 13 SP - 947973 J2 - Front. Psychiatry SN - 1664-0640 ST - Post-COVID-19 fatigue UR - https://www.frontiersin.org/articles/10.3389/fpsyt.2022.947973/full Y2 - 2022/11/21/16:20:29 L1 - https://www.frontiersin.org/articles/10.3389/fpsyt.2022.947973/pdf ER - TY - JOUR TI - Post-COVID syndrome. A case series and comprehensive review AU - Anaya, Juan-Manuel AU - Rojas, Manuel AU - Salinas, Martha L. AU - Rodríguez, Yhojan AU - Roa, Geraldine AU - Lozano, Marcela AU - Rodríguez-Jiménez, Mónica AU - Montoya, Norma AU - Zapata, Elizabeth AU - Monsalve, Diana M. AU - Acosta-Ampudia, Yeny AU - Ramírez-Santana, Carolina T2 - Autoimmunity Reviews DA - 2021/11// PY - 2021 DO - 10.1016/j.autrev.2021.102947 DP - DOI.org (Crossref) VL - 20 IS - 11 SP - 102947 J2 - Autoimmunity Reviews LA - en SN - 15689972 UR - https://linkinghub.elsevier.com/retrieve/pii/S1568997221002226 Y2 - 2022/11/21/16:13:44 L1 - https://www.sciencedirect.com/science/article/pii/S1568997221002226/pdfft?md5=2b0cb3c1aa43c0701dd65b693e2cea06&pid=1-s2.0-S1568997221002226-main.pdf&isDTMRedir=Y ER - TY - GEN TI - Orientaciones para la vigilancia en salud publiva de la COVID-19 AU - Franklyn Edwin Prieto-Alvarado, MD, PhD, FETP AU - Maritza Adegnis González-Duarte, MD, MPH, FETP AU - Claudia Marcella Huguett-Aragón, Bact, MPH, FETP AU - Diana Marcela Walteros-Acero, MD, MSc, FETP AU - Helena Patricia Salas-Suspe, Enf, MPH, FETP (c) AU - Greace Alejandra Avila-Mellizo, Enf, MPH, FETP (c) AU - Milena Edith Borbón-Ramos, Ing, MSc, FETP AU - Jorge Luis Díaz-Moreno, MD, Epid, FETP (c) DA - 2020/07/23/ PY - 2020 LA - Español UR - https://www.ins.gov.co/BibliotecaDigital/orientaciones-vigilancia-salud-publica-covid.pdf ER - TY - JOUR TI - Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients AU - Taquet, Maxime AU - Sillett, Rebecca AU - Zhu, Lena AU - Mendel, Jacob AU - Camplisson, Isabella AU - Dercon, Quentin AU - Harrison, Paul J T2 - The Lancet Psychiatry DA - 2022/10// PY - 2022 DO - 10.1016/S2215-0366(22)00260-7 DP - DOI.org (Crossref) VL - 9 IS - 10 SP - 815 EP - 827 J2 - The Lancet Psychiatry LA - en SN - 22150366 ST - Neurological and psychiatric risk trajectories after SARS-CoV-2 infection UR - https://linkinghub.elsevier.com/retrieve/pii/S2215036622002607 Y2 - 2022/11/21/16:13:08 L1 - https://www.thelancet.com/article/S2215036622002607/pdf ER - TY - JOUR TI - Onset and frequency of depression in post-COVID-19 syndrome: A systematic review AU - Renaud-Charest, Olivier AU - Lui, Leanna M.W. AU - Eskander, Sherry AU - Ceban, Felicia AU - Ho, Roger AU - Di Vincenzo, Joshua D. AU - Rosenblat, Joshua D. AU - Lee, Yena AU - Subramaniapillai, Mehala AU - McIntyre, Roger S. T2 - Journal of Psychiatric Research DA - 2021/12// PY - 2021 DO - 10.1016/j.jpsychires.2021.09.054 DP - DOI.org (Crossref) VL - 144 SP - 129 EP - 137 J2 - Journal of Psychiatric Research LA - en SN - 00223956 ST - Onset and frequency of depression in post-COVID-19 syndrome UR - https://linkinghub.elsevier.com/retrieve/pii/S002239562100594X Y2 - 2022/11/21/16:20:07 L1 - https://www.sciencedirect.com/science/article/pii/S002239562100594X/pdfft?md5=b194078bcc5d5cbb7d8d346dbabbfc1d&pid=1-s2.0-S002239562100594X-main.pdf&isDTMRedir=Y ER - TY - GEN TI - Manual de bioseguridad para prestadores de servicios de salud que brinden atencion en salud ante la eventual introduccion del nuevo coronavirus (NCOV-2019) a Colombia AU - Ministerio de Salud DA - 2020/01/30/ PY - 2020 LA - Español UR - https://www.minsalud.gov.co/Ministerio/Institucional/Procesos%20y%20procedimientos/GIPM01.pdf ER - TY - JOUR TI - Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments AU - Yong, Shin Jie T2 - Infectious Diseases DA - 2021/10/03/ PY - 2021 DO - 10.1080/23744235.2021.1924397 DP - DOI.org (Crossref) VL - 53 IS - 10 SP - 737 EP - 754 J2 - Infectious Diseases LA - en SN - 2374-4235, 2374-4243 ST - Long COVID or post-COVID-19 syndrome UR - https://www.tandfonline.com/doi/full/10.1080/23744235.2021.1924397 Y2 - 2022/11/21/16:18:46 L1 - https://www.tandfonline.com/doi/pdf/10.1080/23744235.2021.1924397?needAccess=true ER - TY - GEN TI - Lineamientos para prevención control y reporte de accidente por exposición ocupacional al covid-19 en instituciones de salud AU - Ministerio de Salud y Protección Social Ministerio de Trabajo DA - 2020/03/01/ PY - 2020 ER - TY - GEN TI - Lineamientos para kit de elementos mínimos de protección para personal de la salud AU - Ministerio de Salud y Protección Social DA - 2020/06/01/ PY - 2020 UR - https://www.minsalud.gov.co/Ministerio/Institucional/Procesos%20y%20procedimientos/GMTG16.pdf ER - TY - GEN TI - Lineamientos para el uso de pruebas diganosticas para SARS-CoV-2 (COVID-19) en Colombia AU - Ministerio de Salud y Protección Social DA - 2022/03/03/ PY - 2022 LA - Español UR - https://www.minsalud.gov.co/Ministerio/Institucional/Procesos%20y%20procedimientos/GIPS21.pdf ER - TY - GEN TI - Lineamientos para el manejo clínico de pacientes con infección por nuevo coronavirus COVID-19 AU - Ministerio de Salud DA - 2020/07/01/ PY - 2020 LA - Español UR - https://www.minsalud.gov.co/Ministerio/Institucional/Procesos%20y%20procedimientos/PSSS03.pdf ER - TY - ELEC TI - Guias CDC Evaluacion de Sistemas de Vigilancia en Salud Publica AU - Center for Disease Control and Prevention DA - 2022/// PY - 2022 UR - https://www.cdc.gov/ ER - TY - GEN TI - Estudio advierte sobre elevados niveles de depresión y pensamientos suicidas en personal de salud de América Latina durante la pandemia AU - Organización Panamericana de Salud DA - 2022/01/17/ PY - 2022 UR - https://www.paho.org/es/noticias/13-1-2022-estudio-advierte-sobre-elevados-niveles-depresion-pensamientos-suicidas-personal ER - TY - GEN TI - Global COVID-19 Clinical Platform Case Report Form (CRF) for Post COVID condition (Post COVID-19 CRF) AU - World Health Organization DA - 2021/02/09/ PY - 2021 UR - https://cdn.who.int/media/docs/default-source/3rd-edl-submissions/who_crf_postcovid_feb9_2021.pdf?sfvrsn=76afd14_1&download=true ER - TY - CHAP TI - 21. Salud Ocupacional y Epidemiología AU - Trillos, Carlos T2 - Fundamentos de Salud Pública. Tomo III. Epidemiología básica y principios de investigación A2 - Blanco Restrepo, Jorge Humberto A2 - Maya Mejía, José María A2 - Torres, Yolanda CY - Medellín, Colombia DA - 2016/// PY - 2016 DP - Open WorldCat ET - Tercera edición SP - 325 EP - 359 LA - spa PB - Corporación para Investigaciones Biológicas SN - 978-958-8843-05-6 ER - TY - GEN TI - Evaluación de casos sospechosos por infección SARS-COV-2 AU - Instituto Nacional de Salud DA - 2020/10/20/ PY - 2020 LA - Español UR - https://www.ins.gov.co/BibliotecaDigital/infografia-ins-20-10-2020-reinfeccion.jpg ER - TY - ELEC TI - Efectos sobre la salud mental del personal de cuidado de la salud, derivados de la atención de pacientes con COVID-19: Revisión de alcance AU - Gaitán Ayala, Lina Paola AU - Osorio Guarnizo, Laura Camila T2 - Repositorio Institucional EdocUR DA - 2022/// PY - 2022 LA - Español UR - https://repository.urosario.edu.co/handle/10336/37587 ER - TY - ELEC TI - Efectos sobre la salud física del personal de cuidado de la salud derivados de la atención de pacuentes con COVID-19: Una revisión de alcance AU - Henao Martínez, Ana Milena AU - Mariño Romero, Nicolas AU - Calderón Cárdenas, Juan sebastian AU - Borda Roncancio, Lorena T2 - Repositorio Institucional EdocUR DA - 2022/// PY - 2022 UR - https://repository.urosario.edu.co/handle/10336/37585 ER - TY - JOUR TI - Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity AU - Jianwei Wang AU - Dana Yelin AU - Laurent Kaiser AU - Isabella Eckerle AU - Christiane S. Eberhardt AU - Dafna Yahav AU - Bin Cao T2 - Clinical Microbiology and Infection DA - 2022/12/05/ PY - 2022 VL - 27 SP - 315 EP - 315-318 J2 - Clinical Microbiology and Infection UR - https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3e86f267182c13f50c10e2311f83ec4 AN - edsair.doi.dedup.....a3e86f267182c13f50c10e2311f83ec4 DB - OpenAIRE Y2 - 2022/09/12/ ER - TY - GEN TI - COVID-19, progreso de la pandemia y su impacto en las desigualdades en Colombia AU - Ministerio de Salud DA - 2021/11/01/ PY - 2021 LA - Español UR - https://www.ins.gov.co/Direcciones/ONS/Informes/13.%20COVID-19,%20progreso%20de%20la%20pandemia%20y%20su%20impacto%20en%20las%20desigualdades%20en%20Colombia.pdf ER - TY - JOUR TI - COVID-19 reinfection: a rapid systematic review of case reports and case series AU - Wang, Jingzhou AU - Kaperak, Christopher AU - Sato, Toshiro AU - Sakuraba, Atsushi T2 - Journal of Investigative Medicine AB - The COVID-19 pandemic has infected millions of people worldwide and many countries have been suffering from a large number of deaths. Acknowledging the ability of SARS-CoV-2 to mutate into distinct strains as an RNA virus and investigating its potential to cause reinfection is important for future health policy guidelines. It was thought that individuals who recovered from COVID-19 generate a robust immune response and develop protective immunity; however, since the first case of documented reinfection of COVID-19 in August 2020, there have been a number of cases with reinfection. Many cases are lacking genomic data of the two infections, and it remains unclear whether they were caused by different strains. In the present study, we undertook a rapid systematic review to identify cases infected with different genetic strains of SARS-CoV-2 confirmed by PCR and viral genome sequencing. A total of 17 cases of genetically confirmed COVID-19 reinfection were found. One immunocompromised patient had mild symptoms with the first infection but developed severe symptoms resulting in death with the second infection. Overall, 68.8% (11/16) had similar severity; 18.8% (3/16) had worse symptoms; and 12.5% (2/16) had milder symptoms with the second episode. Our case series shows that reinfection with different strains is possible, and some cases may experience more severe infections with the second episode. The findings also suggest that COVID-19 may continue to circulate even after achieving herd immunity through natural infection or vaccination, suggesting the need for longer-term transmission mitigation efforts. DA - 2021/08// PY - 2021 DO - 10.1136/jim-2021-001853 DP - DOI.org (Crossref) VL - 69 IS - 6 SP - 1253 EP - 1255 J2 - J Investig Med LA - en SN - 1081-5589, 1708-8267 ST - COVID-19 reinfection UR - https://jim.bmj.com/lookup/doi/10.1136/jim-2021-001853 Y2 - 2022/11/21/16:21:22 L1 - https://jim.bmj.com/content/jim/69/6/1253.full.pdf ER - TY - GEN TI - Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/ COVID-19 en establecimientos de atención de la Salud AU - Londoño, Juan Camilo DA - 2021/02/01/ PY - 2021 LA - Español UR - (https://www.acin.org/index.php/antecedentes-3/antecedentes-9/antecedentes-15) ER - TY - GEN TI - Clinical management of COVID-19: Living guideline AU - World Health Organization DA - 2022/07/15/ PY - 2022 UR - https://www.who.int/publications/i/item/WHO-2019-nCoV-Clinical-2022.2 ER - TY - GEN TI - COVID-19 natural immunity AU - World Health Organization DA - 2021/05/10/ PY - 2021 LA - Ingles ER - TY - ELEC TI - COVID-19 en personal de salud en Colombia | Boletín No. 144| 06-09-2022 AU - Instituto Nacional de Salud T2 - COVID-19 en Colombia DA - 2022/// PY - 2022 LA - Español UR - https://www.ins.gov.co/Noticias/Paginas/coronavirus-personal-salud.aspx ER - TY - ELEC TI - Coronavirus Resource Center AU - Jhons Hopkins University & Medicine DA - 2022/// PY - 2022 LA - Inglés UR - https://coronavirus.jhu.edu/region/colombia ER - TY - ELEC TI - Colombia: tasa de muertes por esquema de vacunación, todas las edades AU - Ministerio de Salud DA - 2022/01/01/ PY - 2022 LA - Español UR - https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/ED/grafica-tasa-muertes-esquema-vacunacion-todas-edades-minsalud.pdf ER - TY - JOUR TI - A clinical case definition of post-COVID-19 condition by a Delphi consensus AU - Soriano, Joan B AU - Murthy, Srinivas AU - Marshall, John C AU - Relan, Pryanka AU - Diaz, Janet V T2 - The Lancet Infectious Diseases DA - 2022/04// PY - 2022 DO - 10.1016/S1473-3099(21)00703-9 DP - DOI.org (Crossref) VL - 22 IS - 4 SP - e102 EP - e107 J2 - The Lancet Infectious Diseases LA - en SN - 14733099 UR - https://linkinghub.elsevier.com/retrieve/pii/S1473309921007039 Y2 - 2022/11/21/18:46:53 L1 - https://www.thelancet.com/article/S1473309921007039/pdf ER - TY - ELEC TI - Archived: WHO Timeline - COVID-19 AU - World Health Organization AB - 31 Dec 2019China reported a cluster of cases of in Wuhan, Hubei Province. A novel coronavirus was eventually identified.1 January 2020WHO had set up the IMST (Incident Management Support Team) across the three levels of the organization: headquarters, regional headquarters and country level, putting the organization on an emergency footing for dealing with the outbreak.4  January 2020WHO reported on social media that there was a cluster of pneumonia cases – with no deaths – in Wuhan, Hubei province. 5 January 2020WHO published our first Disease Outbreak News on the new virus. This is a flagship technical publication to the scientific and public health community as well as global media. It contained a risk assessment and advice, and reported on what China had told the organization about the status of patients and the public health response on the cluster of pneumonia cases in Wuhan.10 January 2020WHO issued a comprehensive package of technical guidance online with advice to all countries on how to detect, test and manage potential cases, based on what was known about the virus at the time. Evidence at that time suggested there was “no or limited human-to-human transmission.” Based on experience with SARS and MERS and known modes of transmission of respiratory viruses, infection and prevention control guidance were published to protect health workers recommending droplet and contact precautions when caring for patients, and airborne precautions for aerosol generating procedures conducted by health workers.  12 January 2020China shared the genetic sequence of COVID-19. 13 January 2020Officials confirm case of COVID-19 in Thailand, the first recorded case outside of China.   14 January 2020 Dr. Maria Van Kerkhove noted in a press briefing there had been limited human-to-human transmission of the coronavirus (in the 41 confirmed cases), mainly through family members, and that there was a risk of a possible wider outbreak. Dr. Kerkhove noted that human-to-human transmission would not be surprising given our experience with SARS, MERS and other respiratory pathogens.  20-21 January 2020WHO experts from its China and Western Pacific regional offices conducted a brief field visit to Wuhan.22 January 2020WHO mission to China issued a statement saying that there was evidence of human-to-human transmission in Wuhan but more investigation was needed to understand the full extent of transmission.22- 23 January 2020The WHO Director- General convened an Emergency Committee (EC) under the International Health Regulations (IHR 2005) to assess whether the outbreak constituted a public health emergency of international concern. The independent members from around the world could not reach a consensus based on the evidence available at the time. They asked to be reconvened within 10 days after receiving more information.28 January 2020A senior WHO delegation led by the Director-General travelled to Beijing to meet China’s leadership, learn more about China’s response, and to offer any technical assistance.  While in Beijing, Dr. Tedros agreed with Chinese government leaders that an international team of leading scientists would travel to China on a mission to better understand the context, the overall response, and exchange information and experience. 11-12 February 2020WHO convened a Research and Innovation Forum on COVID-19, attended by more than 400 experts and funders from around the world, which included presentations by George Gao, Director General of China CDC, and Zunyou Wu, China CDC's chief epidemiologist. 16-24 February 2020The WHO-China Joint mission, which included experts from Canada, Germany, Japan, Nigeria, Republic of Korea, Russia, Singapore and the US (CDC, NIH) spent time in Beijing and also travelled to Wuhan and two other cities. They spoke with health officials, scientists and health workers in health facilities (maintaining physical distancing). The report of the joint mission can be found here: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf DA - 2020/// PY - 2020 LA - en ST - Archived UR - https://www.who.int/news/item/27-04-2020-who-timeline---covid-19 Y2 - 2022/12/07/01:23:29 L2 - https://www.who.int/news/item/27-04-2020-who-timeline---covid-19 ER - TY - JOUR TI - COVID-19 en Colombia: un año después de confirmar su primer caso AU - Díaz Pinzón, Jorge Enrique T2 - Revista Repertorio de Medicina y Cirugía AB - Introducción: la enfermedad por coronavirus 2019 (COVID-19) es una enfermedad respiratoria aguda infecciosa producida por un nuevo coronavirus. La Organización Mundial de la Salud (OMS) fue conocedora de casos de neumonía de etiología microbiana desconocida asociados con la ciudad de Wuhan, provincia de Hubei, China, el 31 de diciembre de 2019. Objetivo: presentar la tendencia de la enfermedad COVID-19, un año después de registrarse el primer caso de contagio en Colombia. Metodología: el trabajo de investigación se realizó mediante un enfoque cuantitativo. Resultados: se calcularon las tasas de letalidad por COVID-19 por meses en Colombia, se apreció que el mes con mayor porcentaje de letalidad por cada 100 habitantes está en primer lugar abril 2020 con una tasa de 4,71%, y febrero 2021 con 3,68%. Para el caso de la incidencia se determinó que el mes con mayor tasa de porcentaje se ubicó en el mes de enero 2021 con 0,884% y diciembre 2020 con 0,664%. En la otra medida epidemiológica de la prevalencia, se fijó que los meses con mayor tasa de porcentaje se ubicó en 2021: enero 4,1%, y febrero con un 4,41%. Conclusión: la letalidad, la incidencia y prevalencia de la enfermedad COVID-19 en Colombia ha tenido una serie de fluctuaciones durante su primer registro de contagio en nuestro país, ahora, con el inicio de la vacunación se genera un espacio para disminuir las tasas de contagio y letalidad. DA - 2021/06/10/ PY - 2021 DO - 10.31260/RepertMedCir.01217372.1182 DP - DOI.org (Crossref) SP - 10 EP - 15 J2 - Repert. Med. Cir. SN - 2462-991X, 0121-7372 ST - COVID-19 en Colombia UR - https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1182 Y2 - 2022/12/07/01:35:07 L1 - https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1182/1571 ER - TY - ELEC TI - Interim Guidance for Managing Healthcare Personnel with SARS-CoV-2 Infection or Exposure to SARS-CoV-2 AU - Center for Disease Control and Prevention T2 - Centers for Disease Control and Prevention AB - COVID-19 guidance, tools, and resources for healthcare workers. DA - 2022/09/23/ PY - 2022 LA - en-us UR - https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html Y2 - 2022/12/07/01:42:36 L2 - https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html ER - TY - JOUR TI - Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study AU - Nguyen, Long H AU - Drew, David A AU - Graham, Mark S AU - Joshi, Amit D AU - Guo, Chuan-Guo AU - Ma, Wenjie AU - Mehta, Raaj S AU - Warner, Erica T AU - Sikavi, Daniel R AU - Lo, Chun-Han AU - Kwon, Sohee AU - Song, Mingyang AU - Mucci, Lorelei A AU - Stampfer, Meir J AU - Willett, Walter C AU - Eliassen, A Heather AU - Hart, Jaime E AU - Chavarro, Jorge E AU - Rich-Edwards, Janet W AU - Davies, Richard AU - Capdevila, Joan AU - Lee, Karla A AU - Lochlainn, Mary Ni AU - Varsavsky, Thomas AU - Sudre, Carole H AU - Cardoso, M Jorge AU - Wolf, Jonathan AU - Spector, Tim D AU - Ourselin, Sebastien AU - Steves, Claire J AU - Chan, Andrew T AU - Albert, Christine M. AU - Andreotti, Gabriella AU - Bala, Bijal AU - Balasubramanian, Bijal A. AU - Beane-Freeman, Laura E. AU - Brownstein, John S. AU - Bruinsma, Fiona J. AU - Coresh, Joe AU - Costa, Rui AU - Cowan, Annie N. AU - Deka, Anusila AU - Deming-Halverson, Sandra L. AU - Elena Martinez, Maria AU - Ernst, Michael E. AU - Figueiredo, Jane C. AU - Fortuna, Pedro AU - Franks, Paul W. AU - Freeman, Laura Beane AU - Gardner, Christopher D. AU - Ghobrial, Irene M. AU - Haiman, Christopher A. AU - Hall, Janet E. AU - Kang, Jae H. AU - Kirpach, Brenda AU - Koenen, Karestan C. AU - Kubzansky, Laura D. AU - Lacey, Jr, James V. AU - Le Marchand, Loic AU - Lin, Xihong AU - Lutsey, Pam AU - Marinac, Catherine R. AU - Martinez, Maria Elena AU - Milne, Roger L. AU - Murray, Anne M. AU - Nash, Denis AU - Palmer, Julie R. AU - Patel, Alpa V. AU - Pierce, Eric AU - Robertson, McKaylee M. AU - Rosenberg, Lynn AU - Sandler, Dale P. AU - Schurman, Shepherd H. AU - Sewalk, Kara AU - Sharma, Shreela V. AU - Sidey-Gibbons, Christopher J. AU - Slevin, Liz AU - Smoller, Jordan W.. AU - Steves, Claire J. AU - Tiirikainen, Maarit I. AU - Weiss, Scott T. AU - Wilkens, Lynne R. AU - Zhang, Feng T2 - The Lancet Public Health DA - 2020/09// PY - 2020 DO - 10.1016/S2468-2667(20)30164-X DP - DOI.org (Crossref) VL - 5 IS - 9 SP - e475 EP - e483 J2 - The Lancet Public Health LA - en SN - 24682667 ST - Risk of COVID-19 among front-line health-care workers and the general community UR - https://linkinghub.elsevier.com/retrieve/pii/S246826672030164X Y2 - 2022/12/07/01:45:17 L1 - https://www.thelancet.com/article/S246826672030164X/pdf ER - TY - ELEC TI - Carlos Fabián Nieto, primer médico que murió por covid-19 en Colombia AU - Ramirez, Sebastián T2 - El Tiempo DA - 2021/// PY - 2021 UR - https://www.eltiempo.com/colombia/otras-ciudades/carlos-fabian-nieto-primer-medico-que-murio-por-covid-19-en-colombia-579948 Y2 - 2022/12/07/02:16:30 L2 - https://www.eltiempo.com/colombia/otras-ciudades/carlos-fabian-nieto-primer-medico-que-murio-por-covid-19-en-colombia-579948 ER - TY - JOUR TI - Physical and mental health complications post-COVID-19: Scoping review AU - Shanbehzadeh, Sanaz AU - Tavahomi, Mahnaz AU - Zanjari, Nasibeh AU - Ebrahimi-Takamjani, Ismail AU - Amiri-arimi, Somayeh T2 - Journal of Psychosomatic Research DA - 2021/08// PY - 2021 DO - 10.1016/j.jpsychores.2021.110525 DP - DOI.org (Crossref) VL - 147 SP - 110525 J2 - Journal of Psychosomatic Research LA - en SN - 00223999 ST - Physical and mental health complications post-COVID-19 UR - https://linkinghub.elsevier.com/retrieve/pii/S0022399921001707 Y2 - 2022/12/07/02:00:59 L1 - https://www.sciencedirect.com/science/article/pii/S0022399921001707/pdfft?md5=c074af13b22c25a6dc4c79421864c762&pid=1-s2.0-S0022399921001707-main.pdf&isDTMRedir=Y ER - TY - ELEC TI - Long COVID or Post-COVID Conditions AU - Center for Disease Control and Prevention DA - 2022/// PY - 2022 LA - Inglés UR - https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html ER - TY - ELEC TI - COVID-19 en personal de salud en Colombia. Boletín No. 153. 08-11-2022 AU - Instituto Nacional de Salud DA - 2022/08/11/ PY - 2022 UR - https://www.ins.gov.co/Noticias/Paginas/coronavirus-personal-salud.aspx Y2 - 2022/12/07/02:32:00 L2 - https://www.ins.gov.co/Noticias/Paginas/coronavirus-personal-salud.aspx ER - TY - ELEC TI - Colombia Has 122,800 Doctors Serving the General Population AU - Ministerio de Salud DA - 2020/12/03/ PY - 2020 M3 - Ministerio de Salud y Protección Social UR - https://www.minsalud.gov.co/English/Paginas/Colombia-Has-122,800-Doctors-Serving-the-General-Population.aspx Y2 - 2022/12/07/02:39:25 L2 - https://www.minsalud.gov.co/English/Paginas/Colombia-Has-122,800-Doctors-Serving-the-General-Population.aspx ER - TY - JOUR TI - Factors Associated With SARS-CoV-2 Infection in Bogotá, Colombia: Results From a Large Epidemiological Surveillance Study AU - Ramirez, Andrea AU - Hernandez, Luis AU - Tamayo-Cabeza, Guillermo AU - Contreras-Arrieta, Sandra AU - Restrepo, Silvia Restrepo AU - Laajaj, Rachid AU - Gutierrez, Giancarlo Buitrago AU - Guevara, Yenny Paola Rueda AU - Caballero-Díaz, Yuldor AU - Florez, Martha Vives AU - Osorio, Elkin AU - Sarmiento, Ignacio AU - Rodriguez, Daniela AU - León, Leonardo AU - Bernal, Raquel AU - Rios, Sofía AU - Salas, Leonardo AU - Guevara-Suarez, Marcela AU - Gaviria, Alejandro AU - Behrentz, Eduardo T2 - The Lancet Regional Health - Americas DA - 2021/10// PY - 2021 DO - 10.1016/j.lana.2021.100048 DP - DOI.org (Crossref) VL - 2 SP - 100048 J2 - The Lancet Regional Health - Americas LA - en SN - 2667193X ST - Factors Associated With SARS-CoV-2 Infection in Bogotá, Colombia UR - https://linkinghub.elsevier.com/retrieve/pii/S2667193X21000405 Y2 - 2022/12/07/03:15:49 L1 - https://www.sciencedirect.com/science/article/pii/S2667193X21000405/pdfft?md5=097bf540bbf44db32e6488a19bce1a7b&pid=1-s2.0-S2667193X21000405-main.pdf&isDTMRedir=Y ER - TY - ELEC TI - Seguimiento de las variantes del SARS-CoV-2 AU - World Health Organization T2 - Tracking SARS-CoV-2 variants DA - 2022/12/01/ PY - 2022 UR - https://www.who.int/es/activities/tracking-SARS-CoV-2-variants Y2 - 2022/12/07/03:38:50 L2 - https://www.who.int/es/activities/tracking-SARS-CoV-2-variants ER - TY - JOUR TI - Coronavirus Pandemic (COVID-19) AU - Mathieu, Edouard AU - Ritchie, Hannah AU - Rodés-Guirao, Lucas AU - Appel, Cameron AU - Giattino, Charlie AU - Hasell, Joe AU - Macdonald, Bobbie AU - Dattani, Saloni AU - Beltekian, Diana AU - Ortiz-Ospina, Esteban AU - Roser, Max T2 - Our World in Data AB - Our vaccination dataset uses the most recent official numbers from governments and health ministries worldwide. Population estimates for per-capita metrics are based on the United Nations World Population Prospects. Income groups are based on the World Bank classification. A full list of our country-specific sources is available at the bottom of this page, and we also answer frequently-asked questions there. DA - 2020/03/05/ PY - 2020 DP - ourworldindata.org J2 - Our World in Data UR - https://ourworldindata.org/covid-vaccinations Y2 - 2022/12/07/03:43:03 L2 - https://ourworldindata.org/covid-vaccinations ER - TY - ELEC TI - World COVID - Coronavirus Statistics - Worldometer AU - Worldometer DA - 2022/// PY - 2022 UR - https://www.worldometers.info/coronavirus/ Y2 - 2022/09/13/ ER - TY - BOOK TI - The impact of COVID-19 on health and care workers: a closer look at deaths AU - World Health Organization CY - Geneva DA - 2021/09// PY - 2021 SP - 26 UR - https://apps.who.int/iris/bitstream/handle/10665/345300/WHO-HWF-WorkingPaper-2021.1-eng.pdf?sequence=1&isAllowed=y ER - TY - JOUR TI - COVID ‐19 infection and the broader impacts of the pandemic on healthcare workers AU - Smallwood, Natasha AU - Harrex, Warren AU - Rees, Megan AU - Willis, Karen AU - Bennett, Catherine M. T2 - Respirology DA - 2022/06// PY - 2022 DO - 10.1111/resp.14208 DP - DOI.org (Crossref) VL - 27 IS - 6 SP - 411 EP - 426 J2 - Respirology LA - en SN - 1323-7799, 1440-1843 ST -